The global blood bags market size reached US$ 265.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 443.2 Million by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.
A blood bag is used for the transfer, collection, storage, and transfusion of blood and its components, including platelets, plasma, and cryoprecipitate. It is generally manufactured from bio-compatible PVC materials and is integrated with collection tubes, needles, needle covers, and clamps. Blood bags are mostly available in the form of Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags. Based on various transfusion types, they can be further classified into single, double, triple, and quadruple blood collection bags. These bags are widely adopted across surgery centers, trauma centers, emergency units, ambulatory facilities, intensive care units, etc.
Blood Bags Market Trends:
The global blood bags market is primarily driven by the rising incidences of fatal accidents along with the wide presence of trauma centers across the world. According to estimates by the World Health Organization, nearly 1.4 million people die each year because of road traffic crashes. Moreover, the high prevalence of several blood-related medical ailments, such as anemia, hemophilia, myeloma, leukemia, etc., is also driving the demand for blood transfusion. Numerous invasive surgical procedures in the field of cardiology, neurology, orthopedics, oncology, etc., are further catalyzing this market for blood bag. Moreover, the rising investments in healthcare infrastructure development are also propelling the establishment of blood banks, medical research laboratories, and diagnostic centers. The introduction of several blood donation programs by various government bodies and non-profit organizations is also augmenting the market for blood bags.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood bags market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application, end user, material and capacity.
Breakup by Product Type:
Single Blood Bag
Double Blood Bag
Triple Blood Bag
Quadruple Blood Bag
Penta Blood Bag
Breakup by Application:
Collection Blood Bag
Transfer Blood Bag
Breakup by End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Blood Banks
Others
Breakup by Material:
Poly Vinyl Chloride Blood Bag
Polyethylene Terephthalate Blood Bag
Others
Breakup by Capacity:
100ml Blood Bag
150ml Blood Bag
250ml Blood Bag
300ml Blood Bag
350ml Blood Bag
400ml Blood Bag
450ml Blood Bag
500ml Blood Bag
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Singapore
Others
Latin America
Brazil
Mexico
Argentina
Others
Middle East and Africa
Turkey
South Africa
Saudi Arabia
UAE
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being AdvaCare Pharma, BL Life Sciences Pvt. Ltd, Demophorius Healthcare Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol Medical India Limited, JMS Co. Ltd., Kawasumi Laboratories Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metric Company and Troge Medical GmbH.
Report Coverage:
Report Features
Details
Base Year of the Analysis
2022
Historical Period
2017-2022
Forecast Period
2023-2028
Units
US$ Million
Segment Coverage
Product Type, Application, End User, Material, Capacity, Region
Region Covered
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Singapore, Brazil, Mexico, Argentina, Turkey, South Africa, Saudi Arabia, UAE
Companies Covered
AdvaCare Pharma, BL Life Sciences Pvt. Ltd, Demophorius Healthcare Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol Medical India Limited, JMS Co. Ltd., Kawasumi Laboratories Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metric Company and Troge Medical GmbH
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global blood bags market was valued at US$ 265.7 Million in2022.
We expect the global blood bags market to exhibit a CAGR of 9% during 2023-2028.
The rising prevalence of several blood-related ailments, such as anemia, hemophilia, leukemia, etc., along with the increasing number of invasive surgical treatment procedures in the field of cardiology, neurology, oncology, etc., is primarily driving the global blood bags market.
The sudden outbreak of the COVID-19 pandemic has led to the growing utilization of blood bags for transportation and transfusion of blood plasma to treat the coronavirus-infected patients.
Based on the product type, the global blood bags market can be divided into single blood bag, double blood bag, triple blood bag, quadruple blood bag, and Penta blood bag. Currently, single blood bag exhibits a clear dominance in the market.
Based on the application, the global blood bags market has been segmented into collection blood bag and transfer blood bag, where collection blood bag currently accounts for the majority of the total market share.
Based on the end user, the global blood bags market can be categorized into hospitals, clinics, ambulatory surgical centers, blood banks, and others. Currently, hospitals exhibit a clear dominance in the market.
Based on the material, the global blood bags market has been divided into poly vinyl chloride blood bag, polyethylene terephthalate blood bag, and others. Among these, poly vinyl chloride blood bag currently holds the largest market share.
Based on the capacity, the global blood bags market can be bifurcated into 100ml blood bag, 150ml blood bag, 250ml blood bag, 300ml blood bag, 350ml blood bag, 400ml blood bag, 450ml blood bag, and 500ml blood bag. Currently, 300ml blood bag accounts for the majority of the global market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global blood bags market include AdvaCare Pharma, BL Life Sciences Pvt. Ltd, Demophorius Healthcare Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol Medical India Limited, JMS Co. Ltd., Kawasumi Laboratories Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metric Company, and Troge Medical GmbH.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
This site uses cookies (including third-party cookies) to record user’s preferences which help us to enhance our services. For further information review our Privacy Policy.
This site uses cookies to improve user experience.Privacy Policy.